JB Chemicals & Pharmaceuticals (JB Chemicals) informed the exchanges today that the company's USFDA approved solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by USFDA with one minor procedural observation. This observation does not impact continuity of company's business and the company would continue its manufacturing activities in cGMP compliant manner. The Company proposes to address this observation in the next 15 days. The said inspection was carried-out from February 03, 2020 to February 07, 2020.
The stock is trading down by more than 1% in trade today.
This is the 10th consecutive successful inspection for this facility.
Stock view:
J B Chemicals & Pharmaceuticals Ltd is currently trading at Rs556 down by Rs5.1 or 0.91% from its previous closing of Rs561.10 on the BSE.
For Quick Trial – 8871888787
or mail us here - support@researchicon.com
or visit - http://www.researchicon.com/free-trial
إرسال تعليق